18219297

Source:http://linkedlifedata.com/resource/pubmed/id/18219297

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001645, umls-concept:C0027051, umls-concept:C0035647, umls-concept:C0038454, umls-concept:C0205419, umls-concept:C1335671
pubmed:issue	3
pubmed:dateCreated	2008-3-3
pubmed:abstractText	The benefits of beta-blocker therapy may depend on underlying genetic susceptibility.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/AG09556, http://linkedlifedata.com/resource/pubmed/grant/HL43201, http://linkedlifedata.com/resource/pubmed/grant/HL60739, http://linkedlifedata.com/resource/pubmed/grant/HL68639, http://linkedlifedata.com/resource/pubmed/grant/HL68986, http://linkedlifedata.com/resource/pubmed/grant/HL73410, http://linkedlifedata.com/resource/pubmed/grant/HL74745
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8803676
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta-1, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta-2
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0895-7061
pubmed:author	pubmed-author:BisJoshua CJC, pubmed-author:HeckbertSusan RSR, pubmed-author:HindorffLucia ALA, pubmed-author:LangeLeslie ALA, pubmed-author:LemaitreRozenn NRN, pubmed-author:LumleyThomas STS, pubmed-author:MarcianteKristin DKD, pubmed-author:PsatyBruce MBM, pubmed-author:RiceKenneth MKM, pubmed-author:SmithNicholas LNL, pubmed-author:SotoodehniaNonaN, pubmed-author:WigginsKerri LKL
pubmed:issnType	Print
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	290-6
pubmed:dateRevised	2009-2-24
pubmed:meshHeading	pubmed-meshheading:18219297-Adrenergic beta-Antagonists, pubmed-meshheading:18219297-Adult, pubmed-meshheading:18219297-Aged, pubmed-meshheading:18219297-Alleles, pubmed-meshheading:18219297-Case-Control Studies, pubmed-meshheading:18219297-Female, pubmed-meshheading:18219297-Genetic Variation, pubmed-meshheading:18219297-Haplotypes, pubmed-meshheading:18219297-Humans, pubmed-meshheading:18219297-Hypertension, pubmed-meshheading:18219297-Logistic Models, pubmed-meshheading:18219297-Male, pubmed-meshheading:18219297-Middle Aged, pubmed-meshheading:18219297-Myocardial Infarction, pubmed-meshheading:18219297-Receptors, Adrenergic, beta-1, pubmed-meshheading:18219297-Receptors, Adrenergic, beta-2, pubmed-meshheading:18219297-Risk Factors, pubmed-meshheading:18219297-Stroke, pubmed-meshheading:18219297-Treatment Outcome
pubmed:year	2008
pubmed:articleTitle	beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
pubmed:affiliation	Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA. rozenl@u.washington.edu
pubmed:publicationType	Journal Article, Research Support, N.I.H., Extramural